Post a Comment Print Share on Facebook
Featured opinion Estados Unidos economía Energía transito

Diagnostics Investments becomes lactose intolerance test control partner

The company reaches 56.

- 9 reads.

Diagnostics Investments becomes lactose intolerance test control partner

The company reaches 56.8% of the capital of Venter Pharma, the start up owner of LacTEST, after investing 5.6 million euros.

Diagnostics Investments has closed a financing round worth 5.6 million euros subscribed by a group of Spanish private investors in order to expand its stake in Venter Pharma, which until the date of the operation,

Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.